Gottfried E Konecny MD

Oncology•Los Angeles, CA

Gynecologic Cancer

Associate Professor, Medicine, University of California Los Angeles David Geffen SOM

Join to View Full Profile

100 UCLA Medical Plz Ste 550Los Angeles, CA 90024
Phone+1 310-206-1214

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 2005 - 2007
Ludwig Maximilian University of Munich Faculty of MedicineClass of 1989

Certifications & Licensure

CA State Medical License 2013 - 2026

Clinical Trials

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer Start of enrollment: 2009 Jan 01
Terminated
Phase 2
Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer Start of enrollment: 2009 Jan 01
Completed
Phase 2
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Start of enrollment: 2011 Jun 01
Completed
Phase 2
A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression Start of enrollment: 2011 Dec 15
Completed
Phase 2
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer Start of enrollment: 2019 Mar 06
Active, not recruiting
Phase 2
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer Start of enrollment: 2020 Oct 16
Recruiting
Phase 2
Rinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) Start of enrollment: 2022 Dec 07
RECRUITING
PHASE1, PHASE2
Roles: Contact
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers Start of enrollment: 2023 Jan 11
RECRUITING
PHASE1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.
Lora Stojanovic, Rachel Abbotts, Kaushelendra Tripathi, Collin M Coon, Saranya Rajendran
Cancer Research. 2025-04-03
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resista...
Toon Van Gorp, Kathleen N Moore, Gottfried E Konecny, Alexandra Leary, Yolanda García-García
The Lancet. Oncology. 2025-04-01
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer ...
Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, Carson Smitherman, Casey Cosgrove
Gynecologic Oncology. 2025-02-21

Press Mentions

Targeted Therapy for Early Breast Cancer and Advances in PSMA PET Scans at ASCOMay 22nd, 2023
UCLA Joins Clinical Trial to Study COVID-19 in People with CancerSeptember 15th, 2020
OncLive® Presents State of the Science Summit™ on Ovarian CancerJune 17th, 2019
Join now to see all

Other Languages

German